Loss of canonical insulin signaling accelerates vascular smooth muscle cell proliferation and migration through changes in p27Kip1 regulation

Endocrinology

Volumn 152, Issue 2, 2011, Pages 651-658

  Lightell Jr , Daniel James ^a   Moss, Stephanie Collier ^a   Woods, Thomas Cooper ^a,b  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P27; RAPAMYCIN;

ARTICLE; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P27; INSULIN; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; POLYMERASE CHAIN REACTION; RECEPTOR, INSULIN; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 79951602737     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0722     Document Type: Article

References (39)

1. Wendt T, Bucciarelli L, Qu W, Lu Y, Yan SF, Stern DM, Schmidt AM 2002 Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes. Curr Atheroscler Rep 4:228-237
2. Maile LA, Capps BE, Ling Y, Xi G, Clemmons DR 2007 Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I. Endocrinology 148:2435-2443 (Pubitemid 46997046)
3. Jones JI, Prevette T, Gockerman A, Clemmons DR 1996 Ligand occupancy of the α-V-β3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci USA 93:2482-2487 (Pubitemid 26104797)
4. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP 1997 Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/ angiotensin II crosstalk. J Clin Invest 100:2158-2169 (Pubitemid 27500137)
5. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H 2000 High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49:1939-1945
6. Taniyama Y, Hitomi H, Shah A, Alexander RW, Griendling KK 2005 Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler Thromb Vasc Biol 25:1142-1147 (Pubitemid 40776600)
7. Nakanishi H, Brewer KA, Exton JH 1993 Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 268:13-16 (Pubitemid 23021278)
8. Kim TN, Kim S, Yang SJ, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM 2010 Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography. Circ Cardiovasc Imaging 3:142-148
9. Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino Sr RB, Savage PJ, Levy D, Fox CS 2009 Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham heart study, 1950 to 2005. Circulation 119:1728-1735
10. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358:2560-2572 (Pubitemid 351831357)
11. Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm Jr RH, Probstfield JL, Simons-Morton DG, Friedewald WT 2008 Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358:2545-2559 (Pubitemid 351831356)
12. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B 2005 Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653 (Pubitemid 41817713)
13. UK Prospective Diabetes Study Group 1998 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865
14. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD 2009 Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360:129-139
15. Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG 1998 Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 82:396-403 (Pubitemid 28101197)
16. Sun J, Marx SO, Chen HJ, Poon M, Marks AR, Rabbani LE 2001 Role for p27(Kip1) in vascular smooth muscle cell migration. Circulation 103:2967-2972 (Pubitemid 32578136)
17. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ 1999 Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99:2164-2170 (Pubitemid 29196802)
18. Hong F, Larrea MD, Doughty C, Kwiatkowski DJ, Squillace R, Slingerland JM 2008 mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol Cell 30:701-711 (Pubitemid 351815130)
19. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM 2004 Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14:1296-1302 (Pubitemid 38991819)
20. Sakata Y, Xiang F, Chen Z, Kiriyama Y, Kamei CN, Simon DI, Chin MT 2004 Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Arterioscler Thromb Vasc Biol 24:2069-2074 (Pubitemid 39482432)
21. Moss SC, Lightell Jr DJ, Marx SO, Marks AR, Woods TC 2010 Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor, p27Kip1. J Biol Chem 285:11991-11997
22. Okamoto H, Obici S, Accili D, Rossetti L 2005 Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest 115:1314-1322 (Pubitemid 40629051)
23. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR 1996 Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 98:2277-2283 (Pubitemid 26394201)
24. Sakakibara K, Kubota K, Worku B, Ryer EJ, Miller JP, Koff A, Kent KC, Liu B 2005 PDGF-BB regulates p27 expression through ERK-dependent RNA turn-over in vascular smooth muscle cells. J Biol Chem 280:25470-25477 (Pubitemid 40962251)
25. Zethelius B, Lithell H, Hales CN, Berne C 2005 Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia 48:862-867
26. Rutter MK, Meigs JB, Sullivan LM, D'Agostino Sr RB, Wilson PW 2005 Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham offspring study. Diabetes 54:3252-3257 (Pubitemid 43334382)
27. Hedblad B, Nilsson P, Engström G, Berglund G, Janzon L 2002 Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med 19:470-475 (Pubitemid 34639157)
28. Peterson RT, Beal PA, Comb MJ, Schreiber SL 2000 FKBP12-rapamycin- associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J Biol Chem 275:7416-7423 (Pubitemid 30146297)
29. Peterson RT, Desai BN, Hardwick JS, Schreiber SL 1999 Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. Proc Natl Acad Sci USA 96:4438-4442 (Pubitemid 29190354)
30. Peterson RT, Schreiber SL 1998 Translation control: connecting mitogens and the ribosome. Curr Biol 8:R248-50
31. Marx SO, Jayaraman T, Go LO, Marks AR 1995 Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 76:412-417
32. Luo Y, Marx SO, Kiyokawa H, Koff A, Massagué J, Marks AR 1996 Rapamycin resistance tied to defective regulation of p27Kip1. Mol Cell Biol 16:6744-6751 (Pubitemid 26389733)
33. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM 2004 p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18:862-876 (Pubitemid 38529656)
34. Gogg S, Smith U, Jansson PA 2009 Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes: the role of endothelin-1. Diabetes 58:2238-2245
35. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL 1999 Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 104:447-457 (Pubitemid 29534329)
36. Jonas M, Edelman ER, Groothuis A, Baker AB, Seifert P, Rogers C 2005 Vascular neointimal formation and signaling pathway activation in response to stent injury in insulin-resistant and diabetic animals. Circ Res 97:725-733 (Pubitemid 41416342)
37. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C 2009 A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 104:476-487
38. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A 2009 Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 284:3728-3738
39. Engberding N, San Martín A, Martin-Garrido A, Koga M, Pounkova L, Lyons E, Lassègue B, Griendling KK 2009 Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 29:408-415